These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 16531255

  • 1. The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis.
    Golay J, Cortiana C, Manganini M, Cazzaniga G, Salvi A, Spinelli O, Bassan R, Barbui T, Biondi A, Rambaldi A, Introna M.
    Haematologica; 2006 Mar; 91(3):322-30. PubMed ID: 16531255
    [Abstract] [Full Text] [Related]

  • 2. Effect of alemtuzumab on neoplastic B cells.
    Golay J, Manganini M, Rambaldi A, Introna M.
    Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398
    [Abstract] [Full Text] [Related]

  • 3. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
    Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA.
    Cancer Res; 2003 Oct 01; 63(19):6453-7. PubMed ID: 14559836
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
    Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, Shipp MA, Kutok JL.
    Clin Cancer Res; 2006 Dec 01; 12(23):7174-9. PubMed ID: 17145843
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H.
    Birhiray RE, Shaw G, Guldan S, Rudolf D, Delmastro D, Santabarbara P, Brettman L.
    Leukemia; 2002 May 01; 16(5):861-4. PubMed ID: 11986948
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2.
    Golay J, Manganini M, Facchinetti V, Gramigna R, Broady R, Borleri G, Rambaldi A, Introna M.
    Haematologica; 2003 Sep 01; 88(9):1002-12. PubMed ID: 12969808
    [Abstract] [Full Text] [Related]

  • 14. Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment.
    Brett SJ, Baxter G, Cooper H, Rowan W, Regan T, Tite J, Rapson N.
    Int Immunol; 1996 Mar 01; 8(3):325-34. PubMed ID: 8671618
    [Abstract] [Full Text] [Related]

  • 15. A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.
    Angiolillo AL, Yu AL, Reaman G, Ingle AM, Secola R, Adamson PC.
    Pediatr Blood Cancer; 2009 Dec 01; 53(6):978-83. PubMed ID: 19637330
    [Abstract] [Full Text] [Related]

  • 16. CD52 ligation induces CD4 and CD8 down modulation in vivo and in vitro.
    Shah A, Lowenstein H, Chant A, Khan A.
    Transpl Int; 2006 Sep 01; 19(9):749-58. PubMed ID: 16918536
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H.
    Lockwood CM, Hale G, Waldman H, Jayne DR.
    Rheumatology (Oxford); 2003 Dec 01; 42(12):1539-44. PubMed ID: 12949252
    [Abstract] [Full Text] [Related]

  • 20. A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.
    Lapalombella R, Zhao X, Triantafillou G, Yu B, Jin Y, Lozanski G, Cheney C, Heerema N, Jarjoura D, Lehman A, Lee LJ, Marcucci G, Lee RJ, Caligiuri MA, Muthusamy N, Byrd JC.
    Clin Cancer Res; 2008 Jan 15; 14(2):569-78. PubMed ID: 18223233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.